Skip to main content
    C

    Creative Medical Technology Holdings Inc (CELZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.82
    +0.05 (+5.89%)

    Market Cap: $6.00M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(10/19)
    Avg Surprise
    -98.86%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.24
    Range$-0.24 - $-0.24
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.40+40.0%
    60d ago$-0.40+40.0%
    30d ago$-0.23-4.3%
    7d ago$-0.240.0%
    Current$-0.24
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.16
    Range$-0.16 - $-0.16
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.16---
    Sep 26EST
    		-$-0.24---
    Jun 26
    Reported Aug 7
    		$-0.41$-0.39-5.13%Miss+14.6%
    Mar 26
    Reported May 8
    		$-0.38$-0.39+2.56%Beat+54.2%
    Dec 25
    Reported Mar 20
    		$-0.80$-0.37-116.22%Miss+28.6%
    Sep 25
    Reported Nov 7
    		$-0.48$-0.48+0.00%Beat+36.0%
    Jun 25
    Reported Aug 8
    		$-0.48$-0.63+23.81%Beat+56.8%
    Mar 25
    Reported May 9
    		$-0.83$-0.52-59.62%Miss-13.7%
    Dec 24
    Reported Mar 14
    		$-1.12$-0.63-77.78%Miss+5.9%
    Sep 24
    Reported Nov 8
    		$-0.75$-0.85+11.76%Beat+26.5%
    Jun 24
    Reported Aug 9
    		$-1.11$-0.84-32.14%Miss-42.3%
    Mar 24
    Reported May 10
    		$-0.73$-1.15+36.52%Beat-4.3%
    Dec 23
    Reported Mar 22
    		$-1.19$-1.13-5.31%Miss-1600.0%
    Sep 23
    Reported Nov 14
    		$-1.02$-0.86-18.60%Miss-45.7%
    Jun 23
    Reported Aug 11
    		$-0.78$-0.83+6.02%Beat+61.0%
    Mar 23
    Reported May 12
    		$-0.70$-1.00+30.00%Beat+61.1%
    Dec 22
    Reported Mar 31
    		$-0.07$-0.07+0.00%Beat+98.3%
    Sep 22
    Reported Nov 10
    		$-0.70$-1.30+46.15%Beat+6.7%
    Jun 22
    Reported Aug 12
    		$-2.00$-1.50-33.33%Miss-60.0%
    Mar 22
    Reported May 13
    		$-1.80$-2.30+21.74%Beat-116.1%
    Dec 21
    Reported Mar 30
    		$-4.16$-0.23-1708.70%Miss+87.0%
    Sep 21
    Reported Dec 6
    		$-0.75N/AN/ABeat-635.7%
    Jun 21
    Reported Aug 16
    		$-1.25N/AN/ABeat-905.4%
    Mar 21
    Reported May 17
    		$11.18N/AN/ABeat+305.3%
    Dec 20
    Reported Mar 17
    		$-31.93N/AN/ABeat-1407.8%
    Sep 20
    Reported Nov 13
    		$0.14N/AN/ABeat+100.1%
    Jun 20
    Reported Aug 14
    		$0.16N/AN/ABeat+100.1%
    Mar 20
    Reported Apr 6
    		$-5.45N/AN/ABeat+12.4%
    Dec 19
    Reported Mar 31
    		$2.44N/AN/ABeat+103.9%
    Sep 19
    Reported Nov 14
    		$-146.51N/AN/ABeat-179.4%
    Jun 19
    Reported Aug 13
    		$-119.36N/AN/ABeat-37339.6%
    Mar 19
    Reported May 20
    		$-6.22N/AN/ABeat-302.0%
    Dec 18
    Reported Mar 31
    		$-61.93N/AN/ABeat-923.8%
    Sep 18
    Reported Nov 14
    		$184.54N/AN/ABeat+9064.4%
    Jun 18
    Reported Aug 2
    		$-0.32N/AN/ABeat-333.2%
    Mar 18
    Reported Jun 30
    		$-1.55N/AN/ABeat-23.6%
    Dec 17
    Reported Mar 29
    		$-6.05N/AN/ABeat-1641.7%
    Sep 17
    Reported Nov 13
    		$-2.06N/AN/ABeat-
    Jun 17
    Reported Aug 14
    		$-0.07N/AN/ABeat-
    Mar 17
    Reported May 10
    		$-1.25N/AN/ABeat-
    Dec 16
    Reported Feb 13
    		$-0.35N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.40EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-208004.00%
    ROE-77.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio12.91xQuick Ratio12.73x
    Trading Statistics
    Beta1.91Avg Volume1.13M
    52-Week High$6.2552-Week Low$0.62

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.86
    SMA 20$0.92
    SMA 50$1.04
    SMA 200$1.65
    EMA 10$0.85
    EMA 20$0.90
    EMA 50$1.01
    EMA 200$1.58

    MACD

    Line: -0.06Signal: -0.05Hist: -0.01

    ADX

    ADX: 19.5+DI: 15.8-DI: 29.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$0.99

    Bollinger Bands

    Upper Band$1.06
    Lower Band$0.77
    %B Position3143%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    38.4

    Momentum Oscillators

    Stoch %K10.3
    Stoch %D8.7
    Williams %R-78.5
    ROC (10d)-13.2%
    Momentum-0.12
    CCI (20d)-136.6
    MFI (14d)31.7

    Volatility Measures

    ATR (14d)$0.07(8.9%)
    StdDev (20d)0.07
    Hist Vol68.1%(High)

    Volume Flow

    VWAP$0.80
    OBV581.9M
    AD Line-387.5M
    CMF (20d)0.273

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.99

    Pivot Points

    R3$0.84
    R2$0.82
    R1$0.80
    Pivot Point$0.78
    S1$0.75
    S2$0.73
    S3$0.71

    Advanced Oscillators

    TSI-20.64
    Ultimate Osc41.0
    KST-150.24

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$3,000$0$0$3,000$3,000$0$8,000$0$3,000$6,000
    Cost of Revenue$0$0$994$0$0$1,200$1,200$0$3,200$0$1,200$2,400
    Gross Profit$0$0$2,006$0$0$1,800$1,800$0$4,800$0$1,800$3,600
    Operating Expenses$1.56M$1.46M$1.95M$1.27M$1.26M$1.66M$1.89M$1.11M$1.63M$1.12M$1.77M$1.55M
    R&D$459,200$541,658$550,077$465,154$501,261$743,304$471,840$581,796$924,749$422,392$349,408$992,722
    SG&A$1.08M$888,640$1.37M$776,821$731,517$888,397$1.39M$498,607$676,086$671,484$1.40M$531,042
    Operating Income$-1,562,163$-1,459,153$-1,945,782$-1,273,034$-1,263,520$-1,660,478$-1,885,734$-1,109,674$-1,625,306$-1,123,147$-1,771,839$-1,543,185
    Interest Income$50,913$55,436$58,108$37,100$30,217$22,381$31,660$69,539$67,578$81,603$93,215$89,233
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-1,511,250$-1,403,717$-1,887,674$-1,235,934$-1,233,303$-1,638,097$-1,854,074$-1,040,135$-1,557,728$-1,041,544$-1,678,574$-1,453,952
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,511,250$-1,403,717$-1,887,674$-1,235,934$-1,233,303$-1,638,097$-1,854,074$-1,040,135$-1,557,728$-1,041,544$-1,678,574$-1,453,952
    EBITDA$-1,542,872$-1,433,925$-1,916,417$-1,241,975$-1,232,778$-1,629,901$-1,863,095$-1,080,403$-1,596,035$-1,093,876$-1,746,318$-1,520,164
    EBIT$-1,562,163$-1,459,153$-1,945,782$-1,273,034$-1,263,520$-1,660,478$-1,885,734$-1,109,674$-1,625,306$-1,123,147$-1,771,839$-1,543,185
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CELZ

    News

    [SCHEDULE 13D] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Major Shareholder Acquisition (>5%)

    This SCHEDULE 13D filing indicates that Creative Medical Technology Holdings, Inc. (CELZ) has increased its ownership in BioDefense...

    Stock Titan•10/2/26•Neutral

    Creative Medical Technology Takes 80% Control of BioDefense in Cash-and-Stock Purchase

    Creative Medical Technology (CELZ) has increased its ownership in BioDefense to 80% through a Stock Purchase Agreement. The company acquired 4,000,000 BioDefense shares for $200,000 in cash and 1,000,000 shares of its...

    TradingView•9/25/26•Somewhat-Bullish

    Form 4 Creative Medical Technology Holdings Inc For: 25 September

    This article reports on a Form 4 filing for Creative Medical Technology Holdings Inc (CELZ) for September 25th. Form 4s are SEC filings that disclose changes in beneficial ownership of a company's securities by insiders....

    Investing.com India•9/25/26•Neutral

    [Form 4] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Insider Trading Activity

    A Form 4 filing reveals that Timothy Warbington, President & CEO and Director of CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)...

    Stock Titan•9/25/26•Neutral

    Form 4 Creative Medical Technology Holdings Inc For: 25 September By Investing.com

    This article reports on the filing of Form 4 by Creative Medical Technology Holdings Inc. on September 25. Form 4 is a document filed with the SEC to disclose changes in beneficial ownership of a company's stock by its...

    Investing.com Nigeria•9/25/26•Neutral

    CELZ Valuation and Fair Value

    P/E
    -0.4x
    P/B
    0.6x
    See GNG's fair value

    CELZ Profitability: Margins, ROIC and FCF

    Operating margin
    -208004.0%
    Net margin
    0.0%
    ROE
    -77.9%
    FCF margin
    -200890.7%

    CELZ Competitors

    CompanyTicker
    WORK Medical Technology Group LTD Ordinary SharesWOK
    Lexaria Bioscience CorpLEXX
    Healthcare Triangle IncHCTI
    EvogeneEVGN
    Zhongchao IncZCMD
    Can Fite Biopharma Ltd ADRCANF
    Reviva Pharmaceuticals Holdings Inc.RVPH
    Imunon IncIMNN

    Sector: Healthcare

    CELZ Bull Case vs Bear Case

    Bear case

    • CELZ beat EPS estimates in 37.5% of its last 8 reported quarters.

    CELZ Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -27.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.24
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About CELZ

    Does CELZ pay dividends?

    Creative Medical Technology Holdings Inc (CELZ) does not currently pay a regular dividend.

    What is CELZ's market cap?

    Creative Medical Technology Holdings Inc (CELZ) has a market capitalization of $6.00M with a current stock price of $0.82.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In